By DKODING Business Wire India New Phase II data show evobrutinib sustained low annualized relapse rates (ARRs) and had no new safety signals at 2.5 years – the longest follow-up of any Bruton’s tyrosine kinase inhibitor in multiple sclerosis (MS) Updated safety data continue to demonstrate patients treated with MAVENCLAD® (cladribine tablets) for their MS […]
Category: Dkoding
By DKODING SAN JOSE, Calif., March 31, 2022 (GLOBE NEWSWIRE) — Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of February 28, 2022, were IntraOp Medical, Revasum, Wrightspeed, Hera Systems, and Pivotal Systems. […]
By DKODING New York, NY, March 31, 2022 (GLOBE NEWSWIRE) — Global SPAC Partners Co. (“Global”) (Nasdaq: “GLSPU” for units, “GLSPT” for subunits and “GLSPW” for warrants) announces the mailing of a definitive proxy statement, dated March 28, 2022 (the “Extension Proxy Statement”), to hold an extraordinary general meeting on April 11, 2022 to extend […]